Class IITerminatedD-0507-2024
Drug recall · May 29, 2024
Vasopressin Injection recall
Why: Subpotent product in addition to having out-of-specification results for impurities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01
- Lots / codes
Lot #: 23061L1C0, Exp 1/31/2025
- Quantity
- 2,352 vials
- Company
- American Regent, Inc., New Albany, OH
- Distribution
- USA Nationwide
- Initiated
- May 13, 2024 · Voluntary: Firm initiated
- Classified
- May 21, 2024
- Reported
- May 29, 2024
- Ended
- December 22, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.